 | • レポートコード：MRC2-11QY03865 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多発性骨髄腫治療のグローバル市場について調査・分析したレポートです。種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）市場規模、用途別（病院、診療所、がん治療・リハビリテーションセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多発性骨髄腫治療の競争状況、市場シェア ・世界の多発性骨髄腫治療市場：種類別市場規模 2015年-2020年（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法） ・世界の多発性骨髄腫治療市場：種類別市場規模予測 2021年-2026年（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法） ・世界の多発性骨髄腫治療市場：用途別市場規模 2015年-2020年（病院、診療所、がん治療・リハビリテーションセンター） ・世界の多発性骨髄腫治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、がん治療・リハビリテーションセンター） ・北米の多発性骨髄腫治療市場分析：米国、カナダ ・ヨーロッパの多発性骨髄腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多発性骨髄腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多発性骨髄腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多発性骨髄腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Roche Holding、Sanofi、Eli Lilly、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. These malignant plasma cells then produce abnormal proteins (m protein) which may cause tumors, damage the kidneys, and impair immune system function.
The global Multiple Myeloma market is anticipated to be mainly driven by increase in ageing population, rising obese population, increase in healthcare expenditure and increased penetration of novel cancer drugs. Some of the significant developments of this industry include upcoming new innovative products in the market, trend of combination therapies, and chance of new players.
Market Analysis and Insights: Global Multiple Myeloma Treatment Market
The global Multiple Myeloma Treatment market size is projected to reach US$ 30460 million by 2026, from US$ 27270 million in 2020, at a CAGR of 10.6%% during 2021-2026.
Global Multiple Myeloma Treatment Scope and Market Size
Multiple Myeloma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Roche Holding
Sanofi
Eli Lilly
Novartis
…
Market segment by Type, the product can be split into
Proteasome Inhibitors
Immunomodulatory Agents (IMiDs)
Histone Deacetylase (HDAC) Inhibitors
Immunotherapy
Cytotoxic Chemotherapy
Market segment by Application, split into
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiple Myeloma Treatment Revenue
1.4 Market by Type
1.4.1 Global Multiple Myeloma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Proteasome Inhibitors
1.4.3 Immunomodulatory Agents (IMiDs)
1.4.4 Histone Deacetylase (HDAC) Inhibitors
1.4.5 Immunotherapy
1.4.6 Cytotoxic Chemotherapy
1.5 Market by Application
1.5.1 Global Multiple Myeloma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Treatment and Rehabilitation Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Treatment Market Perspective (2015-2026)
2.2 Global Multiple Myeloma Treatment Growth Trends by Regions
2.2.1 Multiple Myeloma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Multiple Myeloma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Multiple Myeloma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Multiple Myeloma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Multiple Myeloma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Treatment Players by Market Size
3.1.1 Global Top Multiple Myeloma Treatment Players by Revenue (2015-2020)
3.1.2 Global Multiple Myeloma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Multiple Myeloma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiple Myeloma Treatment Market Concentration Ratio
3.2.1 Global Multiple Myeloma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Treatment Revenue in 2019
3.3 Multiple Myeloma Treatment Key Players Head office and Area Served
3.4 Key Players Multiple Myeloma Treatment Product Solution and Service
3.5 Date of Enter into Multiple Myeloma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Multiple Myeloma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Multiple Myeloma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Multiple Myeloma Treatment Market Size by Application (2015-2020)
5.2 Global Multiple Myeloma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Multiple Myeloma Treatment Market Size (2015-2020)
6.2 Multiple Myeloma Treatment Key Players in North America (2019-2020)
6.3 North America Multiple Myeloma Treatment Market Size by Type (2015-2020)
6.4 North America Multiple Myeloma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Multiple Myeloma Treatment Market Size (2015-2020)
7.2 Multiple Myeloma Treatment Key Players in Europe (2019-2020)
7.3 Europe Multiple Myeloma Treatment Market Size by Type (2015-2020)
7.4 Europe Multiple Myeloma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Multiple Myeloma Treatment Market Size (2015-2020)
8.2 Multiple Myeloma Treatment Key Players in China (2019-2020)
8.3 China Multiple Myeloma Treatment Market Size by Type (2015-2020)
8.4 China Multiple Myeloma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Multiple Myeloma Treatment Market Size (2015-2020)
9.2 Multiple Myeloma Treatment Key Players in Japan (2019-2020)
9.3 Japan Multiple Myeloma Treatment Market Size by Type (2015-2020)
9.4 Japan Multiple Myeloma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Multiple Myeloma Treatment Market Size (2015-2020)
10.2 Multiple Myeloma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiple Myeloma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Multiple Myeloma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Multiple Myeloma Treatment Market Size (2015-2020)
11.2 Multiple Myeloma Treatment Key Players in India (2019-2020)
11.3 India Multiple Myeloma Treatment Market Size by Type (2015-2020)
11.4 India Multiple Myeloma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Multiple Myeloma Treatment Market Size (2015-2020)
12.2 Multiple Myeloma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiple Myeloma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Multiple Myeloma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Multiple Myeloma Treatment Introduction
13.1.4 Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Roche Holding
13.2.1 Roche Holding Company Details
13.2.2 Roche Holding Business Overview
13.2.3 Roche Holding Multiple Myeloma Treatment Introduction
13.2.4 Roche Holding Revenue in Multiple Myeloma Treatment Business (2015-2020)
13.2.5 Roche Holding Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Multiple Myeloma Treatment Introduction
13.3.4 Sanofi Revenue in Multiple Myeloma Treatment Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Multiple Myeloma Treatment Introduction
13.4.4 Eli Lilly Revenue in Multiple Myeloma Treatment Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Multiple Myeloma Treatment Introduction
13.5.4 Novartis Revenue in Multiple Myeloma Treatment Business (2015-2020)
13.5.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Multiple Myeloma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Multiple Myeloma Treatment Revenue
Table 3. Ranking of Global Top Multiple Myeloma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Multiple Myeloma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Proteasome Inhibitors
Table 6. Key Players of Immunomodulatory Agents (IMiDs)
Table 7. Key Players of Histone Deacetylase (HDAC) Inhibitors
Table 8. Key Players of Immunotherapy
Table 9. Key Players of Cytotoxic Chemotherapy
Table 10. Global Multiple Myeloma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Multiple Myeloma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Multiple Myeloma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Multiple Myeloma Treatment Market Share by Regions (2015-2020)
Table 14. Global Multiple Myeloma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Multiple Myeloma Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Multiple Myeloma Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Multiple Myeloma Treatment Players
Table 21. Global Multiple Myeloma Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Multiple Myeloma Treatment Market Share by Players (2015-2020)
Table 23. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Treatment as of 2019)
Table 24. Global Multiple Myeloma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Multiple Myeloma Treatment Product Solution and Service
Table 27. Date of Enter into Multiple Myeloma Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Multiple Myeloma Treatment Market Size Share by Type (2015-2020)
Table 31. Global Multiple Myeloma Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Multiple Myeloma Treatment Market Size Share by Application (2015-2020)
Table 33. Global Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Multiple Myeloma Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 37. North America Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 39. North America Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 43. Europe Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 45. Europe Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 49. China Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 51. China Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 55. Japan Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 57. Japan Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 61. Southeast Asia Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 67. India Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 69. India Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Multiple Myeloma Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Multiple Myeloma Treatment Market Share (2019-2020)
Table 73. Central & South America Multiple Myeloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Multiple Myeloma Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Multiple Myeloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Multiple Myeloma Treatment Market Share by Application (2015-2020)
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Revenue in Multiple Myeloma Treatment Business (2015-2020) (Million US$)
Table 81. Johnson & Johnson Recent Development
Table 82. Roche Holding Company Details
Table 83. Roche Holding Business Overview
Table 84. Roche Holding Product
Table 85. Roche Holding Revenue in Multiple Myeloma Treatment Business (2015-2020) (Million US$)
Table 86. Roche Holding Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Product
Table 90. Sanofi Revenue in Multiple Myeloma Treatment Business (2015-2020) (Million US$)
Table 91. Sanofi Recent Development
Table 92. Eli Lilly Company Details
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Product
Table 95. Eli Lilly Revenue in Multiple Myeloma Treatment Business (2015-2020) (Million US$)
Table 96. Eli Lilly Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Multiple Myeloma Treatment Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Proteasome Inhibitors Features
Figure 3. Immunomodulatory Agents (IMiDs) Features
Figure 4. Histone Deacetylase (HDAC) Inhibitors Features
Figure 5. Immunotherapy Features
Figure 6. Cytotoxic Chemotherapy Features
Figure 7. Global Multiple Myeloma Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 11. Multiple Myeloma Treatment Report Years Considered
Figure 12. Global Multiple Myeloma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Multiple Myeloma Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Multiple Myeloma Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Multiple Myeloma Treatment Market Share by Players in 2019
Figure 17. Global Top Multiple Myeloma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Multiple Myeloma Treatment Revenue in 2019
Figure 19. North America Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Multiple Myeloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…- 多発性骨髄腫治療薬の世界市場（～2026年） Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma i…
- 多発性硬化症治療の世界市場（～2026年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
- 進行型再発性多発性硬化症治療の世界市場（～2026年） Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Progressive R…
- 一次進行型多発性硬化症治療の世界市場（～2026年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Primary Progressi…